Právní předpis byl sestaven k datu 22.05.2026.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
SDĚLENÍ
Ministerstva zdravotnictví
ze xxx 28. xxxxxxxxx 2016
x xxxxxxxxxx složení očkovacích xxxxx xxx pravidelná, xxxxxxxx x mimořádná xxxxxxxx xxx rok 2017
Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Sb., x xxxxxxx veřejného xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx doporučení Xxxxxxx imunizační xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx a xxxxxxxxx xxxxxxxx pro rok 2017:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b (XXxXXxxXXXXXX):
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx méně xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (xxxx Mahoney)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx antigenu
Haemophilus xxxxxxxxxx typus x xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx xxxxxx xxxxxxxxxx jako xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, nákazám vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx anatoxinum xx méně než 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum 25 mikrogramů
Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (MEF-1) 8 X jednotek xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxx X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx tetani xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ³ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx anatoxinum (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx)
|
1 xxxxx (0,5 ml) xxxxxxxx: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 XX* (5 Xx) |
|
Xxxxxxxxx antigeny |
|
|
Pertussis xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 mikrogramy |
|
Fimbriae, xxxx 2 xx 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx |
1,5 xx (0,33 xx xxxxxxx) |
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx jednotky (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx méně než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx antigena:
Pertussis xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx XX3+
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, nákazám xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (DTaPHib):
|
Diphtheriae xxxxxxxxxx |
xxx. 30 xxxxxxxxxxxxx jednotek |
|
Tetani xxxxxxxxxx |
xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (PT) |
25 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx |
(XXX) 25 mikrogramů |
|
Pertactinum (69xX) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx xxxxxxxxxx B |
10 xxxxxxxxxx |
|
xxx anatoxino xxxxxxxx |
20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae typ x:
1 xxxxx lyofilizované xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací xxxxx xxxxx xxxxxx:
Xxxxxx anatoxinum … xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X od 16 xxx x xxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 mikrogramů |
1g) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X x xxxxxx xxxxxxx:
|
Xxxxxxxxx tegiminis xxxxxxxxxxx B |
10 mikrogramů |
1h) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxxxxxxxx virus attenuatum (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx attenuatum (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50 Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx50
1xx) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) … 40 antigenních X xxxxxxxx*
Xxxxx poliomyelitis inactivatum xxxxx 2 (XXX-1) … 8 antigenních X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) … 32 xxxxxxxxxxx D xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx metody.
1i) xxxxxxxx xxxxx proti xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11A, 12X, 14, 15X, 17X,
18X, 19X, 19X, 20, 22X, 23F, 33X … 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx proti xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) očkovací látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
|
Xxxxxxxxxxx anatoxinum |
ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx antigeny: |
|
|
Pertussis xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx: |
|
|
xxxxx 1 (xxxx Xxxxxxx) |
40 X xxxxxxxx xxxxxxxx |
|
xxxxx 2 (kmen XXX-1) |
8 X jednotek xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
2 X xxxxxxxx xxxxxxxx |
XXXX
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 2 mezinárodní xxxxxxxx (2 Lf) |
|
Tetanický toxoid |
více xxxx rovno 20 xxxxxxxxxxxxx jednotek (5 Xx) |
|
Xxxxxxxxx xxxxxxxx: |
|
|
&xxxx;&xxxx; Pertusový xxxxxx |
2,5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Fimbrie xxxx 2+3 |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx typu 2 (xxxxxxxxxxxx) |
8 antigenních D xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx typu 3 (inaktivovaný) |
32 antigenních X xxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx tuberkulóze (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx do xxxxxxxxxxxx programu:
Antigenum tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (MPL) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx B xx xxxxxxx pro xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx hepatitidis X |
20 xxxxxxxxxx |
2x) očkovací xxxxx xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx dospělé:
Hepatitis X xxxxx inactivatum
3b) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx pro děti:
Virus xxxxxxxxx X xxxxxxxxxxx
X xxxx 2017 x xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxx vyloučit xxxxxxxxx xxxxxx antigenního xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx látek xx Sbírce xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, XXX, v. x.
Informace
Právní předpis x. 390/2016 Xx. nabyl xxxxxxxxx dnem 17.12.2016.
Xx xxx uzávěrky právní xxxxxxx nebyl xxxxx xx xxxxxxxxx.
Xxxxx jednotlivých xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.